Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Efficacy and Safety of TSL-1502 Capsules in Breast Cancer Patients With Germline BRCA Mutations (NCT05420779) | Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. | 2022-06-30 |
Track Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.